IMPORTANT INFORMATION ABOUT UPTRAVI

• Before you take UPTRAVI, tell your healthcare provider if you have narrowing of the pulmonary veins, a condition called pulmonary veno-occlusive disease.¹

summary

• UPTRAVI does not contain lactose in a listing of inactive ingredients included in the PATIENT INFORMATION, “What are the ingredients in UPTRAVI?” section.¹

What are the ingredients in UPTRAVI?

• UPTRAVI tablets¹
  • Active ingredient: selexipag
  • Inactive ingredients: corn starch, D-mannitol, hydroxypropyl cellulose, low substituted hydroxypropyl cellulose, and magnesium stearate. The tablets are film coated with a coating material containing carnauba wax, hypromellose, propylene glycol, titanium dioxide, along with mixtures of iron oxide black, iron oxide red, or iron oxide yellow
• UPTRAVI for injection¹
  • Active ingredient: selexipag
  • Inactive ingredients: glycine, phosphoric acid, polysorbate 20, and sodium hydroxide

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for UPTRAVI.¹